Evidence map›Paper›PMID 12604004›Full record

ArticleEmerging infectious diseases2003

Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.

Antti Hakanen, Hannele Jousimies-Somer, Anja Siitonen, Pentti Huovinen, Pirkko Kotilainen

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 90 citations in OpenAlex.

  1. Role of phage therapy in acute gastroenteritis.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Review
  2. Consortium ofAntibiotics (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Travel-Related Antimicrobial Resistance: A Systematic Review.Tropical medicine and infectious disease · 2021
    Review
  6. Emergence of Fluoroquinolone-ResistantApplied and environmental microbiology · 2020
    Article
  7. Multidrug-resistantF1000Research · 2020
    Article
  8. Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction byInternational journal of molecular sciences · 2019
    Article
  9. Article
  10. The prevalence ofGut pathogens · 2018
    Review
  11. Article
  12. Journal of preventive medicine and hygiene · 2017
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Antti HakanenNational Public Health Institute, Turku, Finland. antti.hakanen@utu.fi
Hannele Jousimies-Somer
Anja Siitonen
Pentti Huovinen
Pirkko Kotilainen
Institute for Molecular Medicine Finland · FITurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciprofloxacin resistance was analyzed in 354 Campylobacter jejuni isolates collected during two study periods (1995-1997 and 1998-2000) from travelers returning to Finland. The increase in resistance between the two periods was significant among all isolates (40% vs. 60%; p<0.01), as well as among those from Asia alone (45% vs. 72%; p<0.01).

Indexed as

Drug Resistance, MicrobialTravelAnti-Infective AgentsCampylobacter InfectionsCampylobacter jejuniCiprofloxacinFecesFinlandHumansMicrobial Sensitivity TestsAnti-Infective AgentsCiprofloxacin

Identifiers

PMID12604004
PMCPMC2901943
OpenAlexW2023146597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.